90
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Real-World Analysis of the Efficacy and Safety of a Novel Irreversible HER2 Tyrosine Kinase Inhibitor Pyrotinib in Patients with HER2-Positive Metastatic Breast Cancer

, , , ORCID Icon, , & show all
Pages 7165-7174 | Published online: 14 Sep 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Articles from other publishers (6)